Table 4 Comparison in efficacy and safety between the two study periods
Variables | IHD sessions in 2015 (n = 116) | IHD sessions in 2017 (n = 92) | p-value |
|---|---|---|---|
IHD session with RCA, n (%) | 76 (65.5) | 48 (52.1) | 0.97 |
Kt/V at the end of session | 0.93 ± 0.35 | 0.92 ± 0.38 | 0.84 |
Kt/V at the end of session with RCA | 0.97 ± 0.37 | 0.91 ± 0.41 | 0.72 |
Kt/V at the end of session with heparin | 0.86 ± 0.30 | 0.92 ± 0.33 | 0.59 |
Causes of premature termination of session, n(%) | |||
 Acute high transmembrane pressure | 21(18) | 11 (12) | 0.23 |
 Circuit clotting | 11 (9.5) | 7 (7.6) | 0.63 |